Abstract. Synthetic hGHRH was incubated with dispersed pituitary cells from 14 human fetuses at 14\p=n-\23 weeks offetal age. After at least three days following plating the cells on an extracellular matrix in serum-containing medium, 3 h incubation with hGHRH in serum-free medium induced a significant increase in GH secretion into the medium at concentrations of hGHRH of 0.01 nmol/1 or higher. After 24 h exposure to 0.5 nmol/l hGHRH, subsequent incubation with 0.5 nmol/l hGHRH for 3 h induced significantly lower GH secretion into the medium compared to the GH secretion by cells exposed previously to medium alone. In contrast, when the subsequent exposure to hGHRH was at 10-fold higher concentrations than the concentration present in the initial exposure, GH secretion into the medium did not significantly decrease compared to previously untreated cells. These results suggest that desensitization (down-regula- (2, (16) (17) (18) (19) . Pitui¬ tary responsiveness to GHRH is markedly greater in the young rat than in postweaning rats, and re¬ peated administration of GHRH to infant rats stimulates GH synthesis and release (17) .
nmol/1 or higher. After 24 h exposure to 0.5 nmol/l hGHRH, subsequent incubation with 0.5 nmol/l hGHRH for 3 h induced significantly lower GH secretion into the medium compared to the GH secretion by cells exposed previously to medium alone. In contrast, when the subsequent exposure to hGHRH was at 10-fold higher concentrations than the concentration present in the initial exposure, GH secretion into the medium did not significantly decrease compared to previously untreated cells. These results suggest that desensitization (down-regulation) of GHRH receptors on somatotropes may be involved in the mechanism by which prior GHRH exposure inhibits GH secretion in response to subsequent GHRH administration. Such desensitization seems to occur in the human fetus but is incomplete. The desensitization may be overcome by increasing the GHRH concentrations with subsequent exposure, suggesting that cellular GH depletion is not responsible for the decreased responsiveness observed.
Growth hormone secretion from the anterior pi¬ tuitary is under both positive and negative hypothalamic regulation. Somatostatin exerts a major inhibitory influence (1) (2) (3) . Growth hormone-re¬ leasing hormone, which was more recently isolated and characterized from human pancreatic islet cell tumours (hGHRH) (2, (4) (5) (6) and rat hypothalami (7) , exhibits potent GH-releasing activity both in vivo (2, 3, (8) (9) (10) and in vitro (2, 4, (11) (12) (13) (14) (21, 22) . The ECM pro¬ duced by BCE has now been used extensively for the cul¬ ture of various normal and neoplastic cells (23) . The use of this matrix had provided a successful means of culturing human pituitary adenoma cells, which adhere poorly to plastic (21, 22) . The use of ECM also can circumvent the need for various attachment factors in serum (23, 24) .
Culture of bovine corneal endothelial cells and the pro¬ duction of ECM were performed according to the method of Gospodarowicz et al. (23) . In brief, for matrix production, stock cultures of corneal endothelium were split with STV, and the corneal endothelial cells (3 X 104/ ml) were plated in 24-well plates with DME containing (NH,OH) for 10 min at 37°C. After this time, during which all cells were lysed, the medium was collected and each well washed again with 250 (il NH4OH and collected for GH measurement by RIA. The number of cells/well in a representative experiment was 530 000 ± 50 000 at the completion of the experiment.
Radioimmunoassay
Growth hormone secretion into the medium was deter¬ mined by RIA using chloramine T-labelled hGH as radioligand, and hGH antiserum at a final dilution of 1:8000000 (10 (Fig. 1) . Twenty-four h incubation with 0.5 nmol/1 hGHRH resulted in a significant increase (3-5-fold) in GH secretion (Fig. 2) (Fig. 4) . (27) and in vivo (10) and in adult men (15) .
Our findings of stimulation of GH secretion by (27) . Hor¬ mone desensitization, in most cases, appears to re¬ sult from a loss of receptors rather than a change in the affinity of the ligand for the receptor (30) . (28, 29) . The ontogeny of the desen¬ sitization phenomenon observed in the adult may occur at different ages in different hormone-pro¬ ducing organs.
